Group picture of the first CPAnet symposium on 30th and 31st March 2017at the Resersch Center Borstel in Germany

“Chronic pulmonary aspergillosis (CPA) is a severe fungal infection with a high morbidity and mortality, and is usually seen in immunocompetent patients with respiratory disorders. Clinical presentation is nonspecific and often overlaps with the symptoms and the radiological pattern caused by the underlying disease. Clinical management of CPA is further hampered by limited information about the epidemiology, disease dynamics, sensitivity and specificity of different mycological tests, mechanisms of antifungal resistance, efficient treatment and management strategies. In order to contribute to a better understanding and to improve CPA patient management and outcome, we established in March 2017 the Chronic Pulmonary Aspergillosis Network (CPAnet), a self-organized multinational research collaboration to promote clinically oriented research in the field of CPA by sharing and developing research ideas and protocols. (Godet C. et al. JAC 2018).”

Steering Committee

Research Center Borstel, Germany

Helmut J. F. Salzer


Instituto de Salud Carlos III, Madrid, Spain

Ana Alastruey-Izquierdo

Deputy Chair

CHU de Poitiers, Service des Maladies Infectieuses et Tropicales, Poitiers, France

Cendrine Godet


Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK

Iain Page


University Hospital Cologne, Cologne, Germany

Danila Seidel

State University of Medicine and Pharmacy ‘Nicolae Testemitanu’, Chisinau, Republic of Moldova

Oxana Munteanu

Medical University of Graz, Graz, Austria

Holger Flick

Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France

Christophe Hennequin